Cosgrove Delos M. 4

What Happened

• Delos M. Cosgrove, a director of Hims & Hers Health, Inc. (HIMS), reported a derivative conversion (Form 4 code M) on 2026-06-11 converting 3,656 restricted stock units (RSUs) into 3,656 shares. The filing also reports a simultaneous disposition of 3,656 shares at $0.00 (reported proceeds $0).
• The entries reflect conversion/settlement of RSUs rather than an open-market sale or cash purchase; the $0.00 disposed amount is consistent with net settlement or share surrender practices rather than a cash sale.

Key Details

• Transaction date: 2026-06-11; Form 4 filed: 2026-06-15 (covering the 06-11 transaction).
• Transaction type: M (exercise/conversion of derivative — RSU conversion).
• Shares converted/acquired: 3,656; Shares disposed: 3,656; Reported proceeds for disposed shares: $0.00.
• Footnote: RSUs convert to one share per RSU and were subject to vesting — vest on the earlier of the 2026 annual meeting or June 15, 2026.
• Shares owned after the transaction: not stated in the provided filing excerpt.
• Filing timeliness: Form 4 filed within the standard reporting window covering the 06-11 transaction.

Context

• For retail investors: this is a conversion of vested RSUs to stock, not a typical buy or cash sale that signals directional insider buying or selling. Reporting of $0 proceeds usually reflects net settlement or surrender of shares (commonly to cover tax obligations) rather than a market sale.